Tactile Systems Technology, Inc. (NASDAQ:TCMD) Director William W. Burke sold 2,000 shares of the business’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $28.86, for a total transaction of $57,720.00. Following the completion of the sale, the director now directly owns 6,306 shares of the company’s stock, valued at $181,991.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Tactile Systems Technology, Inc. (TCMD) traded down $0.53 during mid-day trading on Thursday, hitting $26.66. 178,400 shares of the company’s stock were exchanged, compared to its average volume of 203,962. Tactile Systems Technology, Inc. has a 12-month low of $14.37 and a 12-month high of $37.88. The stock has a market capitalization of $481.31, a PE ratio of 181.27, a price-to-earnings-growth ratio of 4.46 and a beta of -0.69.
Tactile Systems Technology (NASDAQ:TCMD) last released its quarterly earnings data on Tuesday, November 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.02. Tactile Systems Technology had a net margin of 5.84% and a return on equity of 4.75%. The firm had revenue of $28.28 million for the quarter, compared to analysts’ expectations of $27.66 million. During the same quarter in the previous year, the company earned $0.01 earnings per share. The company’s revenue for the quarter was up 25.0% compared to the same quarter last year. equities research analysts anticipate that Tactile Systems Technology, Inc. will post 0.31 earnings per share for the current fiscal year.
Several analysts have weighed in on TCMD shares. Zacks Investment Research raised shares of Tactile Systems Technology from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a research note on Thursday, August 10th. Guggenheim started coverage on shares of Tactile Systems Technology in a research note on Thursday, October 12th. They issued a “buy” rating and a $47.00 price target for the company. Northland Securities started coverage on shares of Tactile Systems Technology in a research note on Tuesday, October 17th. They issued a “market perform” rating for the company. Finally, BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Monday, September 18th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $34.25.
About Tactile Systems Technology
Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.
What are top analysts saying about Tactile Systems Technology Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Tactile Systems Technology Inc. and related companies.